Market Research Logo

Global Computational Biology Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Global Computational Biology Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Computational biology is the branch of medical science which deals with biological data in order to develop models or algorithms for further analysis of various biological systems and medicinal drugs. It includes many aspects of bioinformatics. The applications of the computational biology is boosting the growth of the market with a CAGR of around 21 % during the forecast period 2016-2023. It facilitates reduction of chances for humans to consume test drugs in the development phase, easy to use, provides high data accuracy etc. Due to several advantages offered by computational biology, this technology is being extensively used in large number of applications in academics, industrial and commercial sectors.

North America has emerged as the largest market for computational biology market. The key factors contributing the growth of market in North America are the growing initiatives and investments for research and development of drug discovery, technologies of disease modeling and modernization in the existing biological computation methods. Asia pacific is the fastest growing region and is anticipated to account for large computational biology market growth with a CAGR of around 29% during the forecast period. The key reason for this growth is the increasing investments in clinical studies for pharmacokinetics and pharmacogenomics.

The global computational biology market is influenced by the presence of leading companies such as Certara (u.s.), Chemical Computing Group inc. (Canada), Insilico Biotechnology AG (Germany), Compugen ltd. (Israel) etc. Product launches, joint ventures, mergers and acquisitions are some of the crucial strategies adopted by the key market players to gain competitive advantage.

Global computational biology market report covers segmentation analysis of tools, services applications and end users. Report further covers segments of tools which include Databases, Infrastructure (Hardware) and Analysis Software & Services. Among these segments, databases segment had dominated the tools segment. This was due to the massive genomic database usage for data mining and warehousing of biological and sequential data. Moreover, the analysis software and services segment used for the analysis of biological data is the fastest growing segment with a CAGR of over 21% during the forecasted period. Whereas, applications of computational biology include cellular & biological simulation, drug discovery and disease modeling, preclinical drug development, clinical trials and human body simulation software. The cellular simulation application is the fastest growing segment due to the transition in sequencing studies towards detailed analysis of the characteristics of various biological protein. Furthermore, drug discovery and disease modeling application segment had dominated the global computational biology market. The key factor attributing to the growth of this segment is the large number of drug development pipelines which are currently deployed for several global leading generic drug manufacturing industries.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL COMPUTATIONAL BIOLOGY MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTER'S 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS AND TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASING USAGE OF COMPUTATIONAL BIOLOGY
3.1.2. INCREASING NUMBER OF CLINICAL STUDIES IN PHARMACOGENOMICS AND PHARMACOKINETICS
3.1.3. LARGE APPLICATIONS FOR BIOINFORMATICS R&D PROGRAMS
3.1.4. GROWTH OF DRUG DESIGNING
3.2. MARKET RESTRAINTS
3.2.1. LACK OF STANDARDIZATION OF COMPUTATIONAL BIOLOGY TOOLS
3.3. MARKET OPPORTUNITIES
3.3.1. ADOPTION OF CLOUD COMPUTING IN COMPUTATIONAL BIOLOGY
3.3.2. USE OF MODELING AND SIMULATION
3.3.3. TECHNOLOGICAL ADVANCEMENT
3.4. MARKET CHALLENGES
3.4.1. DATA STORAGE ISSUES
3.4.2. CONSTANT ADDITION OF NEW GENOMES INTO DATABASES
3.4.3. LACK OF SKILLED PROFESSIONALS
4. MARKET SEGMENTATION
4.1. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY TOOLS
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL DATABASE MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL HARDWARE INFRASTRUCTURE MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL ANALYSIS SOFTWARE AND SERVICES MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY SERVICES
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL IN-HOUSE COMPUTATIONAL BIOLOGY MARKET
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL EXTERNAL/CONTRACT COMPUTATIONAL BIOLOGY MARKET
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.4. KEY CONCLUSIONS
4.3. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY APPLICATIONS
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL CELLULAR AND BIOLOGICAL SIMULATION MARKET
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL DRUG DISCOVERY AND DISEASE MODELLING MARKET
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.3. GLOBAL PRECLINICAL DRUG DEVELOPMENT MARKET
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.4. KEY CONCLUSIONS
4.3.5.4. GLOBAL CLINICAL TRIALS MARKET
4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.3. TOP PLAYERS & KEY PRODUCTS
4.3.5.4.4. KEY CONCLUSIONS
4.3.5.5. GLOBAL HUMAN BODY SIMULATION SOFTWARE MARKET
4.3.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.3. TOP PLAYERS & KEY PRODUCTS
4.3.5.5.4. KEY CONCLUSIONS
4.4. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY END USER
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION
4.4.5.1. GLOBAL ACAMEDICS MARKET
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL INDUSTRIAL MARKET
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL COMMERCIAL MARKET
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.4.5.3.4. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. CERTARA (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. ACCELRYS (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. CHEMICAL COMPUTING GROUP INC. (CANADA)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. ENTELOS (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. COMPUGEN LTD. (ISRAEL)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. INSILICO BIOTECHNOLOGY AG (GERMANY)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. GENEDATA AG (SWITZERLAND)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. SANOFI PASTEUR (FRANCE)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. ROCHE (SWITZERLAND)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. NOVARTIS (SWITZERLAND)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. PFIZER (U.S.)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. SIMULATION PLUS INC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. SCHRODINGER LLC ( U.S.)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. LEADSCOPE INC. ( U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. NIMBUS TECHNOLOGY LLC ( U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL COMPUTATIONAL BIOLOGY MARKET BY TOOLS 2014-2023 ($ MILLION)
GLOBAL DATABASE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL HARDWARE INFRASTRUCTURE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL ANALYSIS SOFTWARE AND SERVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL COMPUTATIONAL BIOLOGY MARKET BY SERVICES 2014-2023 ($ MILLION)
GLOBAL IN-HOUSE COMPUTATIONAL BIOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL EXTERNAL/CONTRACT COMPUTATIONAL BIOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL COMPUTATIONAL BIOLOGY MARKET BY APPLICATIONS 2014-2023 ($ MILLION)
GLOBAL CELLULAR AND BIOLOGICAL SIMULATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL DRUG DISCOVERY AND DISEASE MODELLING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL PRECLINICAL DRUG DEVELOPMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL CLINICAL TRIALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL HUMAN BODY SIMULATION SOFTWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL COMPUTATIONAL BIOLOGY MARKET BY END USER 2014-2023 ($ MILLION)
GLOBAL ACAMEDICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL INDUSTRIAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL COMMERCIAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
EUROPE COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
REST OF THE WORLD COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
LIST OF FIGURES
GLOBAL COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL DATABASE MARKET 2014-2023 ($ MILLION)
GLOBAL HARDWARE INFRASTRUCTURE MARKET 2014-2023 ($ MILLION)
GLOBAL ANALYSIS SOFTWARE AND SERVICES MARKET 2014-2023 ($ MILLION)
GLOBAL IN-HOUSE COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL EXTERNAL/CONTRACT COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL CELLULAR AND BIOLOGICAL SIMULATION MARKET 2014-2023 ($ MILLION)
GLOBAL DRUG DISCOVERY AND DISEASE MODELLING MARKET 2014-2023 ($ MILLION)
GLOBAL PRECLINICAL DRUG DEVELOPMENT MARKET 2014-2023 ($ MILLION)
GLOBAL CLINICAL TRIALS MARKET 2014-2023 ($ MILLION)
GLOBAL HUMAN BODY SIMULATION SOFTWARE MARKET 2014-2023 ($ MILLION)
GLOBAL ACAMEDICS MARKET 2014-2023 ($ MILLION)
GLOBAL INDUSTRIAL MARKET 2014-2023 ($ MILLION)
GLOBAL COMMERCIAL MARKET 2014-2023 ($ MILLION)
UNITED STATES (U.S.) COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
CANADA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
UNITED KINGDOM (UK) COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
FRANCE COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
GERMANY COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
SPAIN COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
ROE COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
INDIA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
CHINA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
JAPAN COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
AUSTRALIA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
ROAPAC COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
MENA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report